l-Glucose has recently been investigated as an artificial sweetener, but no facile method is established for the measurement of l-glucose. The commercial probe Eversense employs a fluorescent diboronate in a small device for the optical monitoring of d-glucose in people with diabetes. Being achiral, the Eversense probe should be able to detect l-glucose as well as native d-glucose, but the probe is designed for fixation under the skin, and our attempts to use the probe at laboratory conditions failed, as the probe was resetting when moved between compartments. We thus designed a water-soluble anthracene diboronate 8 similar to the fluorophore used in Eversense and found 8 to respond well to l-glucose and other carbohydrates and artificial sweeteners, thus enabling measurements of l-glucose with the limit of quantification of 12 μM. Notably, the fluorescent signal of diboronate 8 was largely quenched in buffers with the physiological concentration of albumin (0.5 mM), so the given analytical method would need more optimization to be useful for measuring l-glucose and other carbohydrates in blood samples. We suspect that other diboronate fluorophores from the literature may be similarly quenched if applied in the presence of albumin.
l-Glucose has recently been investigated as an artificial sweetener, but no facile method is established for the measurement of l-glucose. The commercial probe Eversense employs a fluorescent diboronate in a small device for the optical monitoring of d-glucose in people with diabetes. Being achiral, the Eversense probe should be able to detect l-glucose as well as native d-glucose, but the probe is designed for fixation under the skin, and our attempts to use the probe at laboratory conditions failed, as the probe was resetting when moved between compartments. We thus designed a water-soluble anthracene diboronate 8 similar to the fluorophore used in Eversense and found 8 to respond well to l-glucose and other carbohydrates and artificial sweeteners, thus enabling measurements of l-glucose with the limit of quantification of 12 μM. Notably, the fluorescent signal of diboronate 8 was largely quenched in buffers with the physiological concentration of albumin (0.5 mM), so the given analytical method would need more optimization to be useful for measuring l-glucose and other carbohydrates in blood samples. We suspect that other diboronate fluorophores from the literature may be similarly quenched if applied in the presence of albumin.
Artificial sweeteners
are commonly used as low-calorie replacement
for added sugars in food, replacing mainly d-sucrose, d-glucose, and d-fructose.[1] Some people have hesitations toward “artificial” sweeteners,
and although this is poorly grounded from a scientific viewpoint,
there is a drive toward finding “natural” low-calorie
sweeteners. l-glucose has been investigated in this regard,[2−5] and we took interest in measuring l-glucose in aqueous
buffers and blood samples. Monitoring of blood d-glucose
is important for the treatment of diabetes, and various devices are
available for fast d-glucose measurements, using “strips”
with handy glucometers for spot checks of d-glucose in small
blood samples (finger pricks), or using small electrodes that are
inserted under the skin, for continuous d-glucose readings
over days or weeks. However, most of such devices use glucose oxidase
or other enzymes, which respond to d-glucose, but are inert
to the L-enantiomer. The exception is Eversense,[6−8] which is a small
probe to be inserted under the skin and which employs a fluorescent
anthracene diboronate for the optical monitoring of d-glucose
in the interstitial fluid continuously over weeks/months. Being achiral
(nonenzymatic), the Eversense diboronate should respond to l-glucose as well as d-glucose, so theoretically, l-glucose concentrations could be measured as [total glucose value]
minus [d-glucose value], with d-glucose measured
using glucometers as mentioned above. We tried to use the Eversense
sensor for the measurements of l-glucose in simple buffers,
but we found that the sensor was not suited for laboratory works.
The sensor is connected to a mobile phone app and must be calibrated
daily against glucometer readings. When carefully moved between vials,
the sensor was resetting constantly, thus requiring repeated time-consuming
and erratic recalibrations. We thus decided to make the Eversense
fluorophore in an isolated form, without the device. Notably, the
diboronate in the Eversense probe is immobilized in the sealed probe
via polymerization of alkene 9 with the matrix components,
so the Eversense fluorophore is not directly suited for use in aqueous
solution. We therefore redesigned the Eversense diboronate for better
water solubility, replacing the alkene with carboxylate, so that the
fluorophore can be used in simple aqueous buffer and potentially with
blood samples. Our diboronate fluorophore 8 is similar
to Shinkai and James’ classical anthracene diboronate 10 (Chart ).[9] However, like most diboronates from
the older literature, the classical diboronate 10 is
not well soluble in water. For this reason, prior studies on diboronates
for carbohydrate measurements often employ partial organic solvents
(typically 50% methanol).[10−13] Diboronate 8 is well soluble in water
and thus directly applicable to measurements in aqueous solutions.
However, when tried with buffers including albumin in native concentration
(0.5 mM), we found the fluorescent signal to be largely quenched.
Chart 1
Shinkai/James Diboronate Fluorophore 10, Eversense Fluorophore 9 (Before Immobilization in Probe), and Water-Soluble Fluorophore 8
Experimental Section
Unless stated otherwise, reagents and solvents were sourced from
commercial suppliers and were used directly as received. LCMS apparatus
was Waters Acquity UPLC SQD 2000. NMR apparatus was Bruker Avance
III HD 300 MHz. Fluorometer was a Tecan Spark multimode microplate
reader.
Synthesis of Diamino Anthracene 3
9,10-Bis(chloromethyl)anthracene 1 (2.75 g, 10.0 mmol) and tert-butyl 3-aminopropanoate-methane
hydrochloride 2 (14.5 g, 80.0 mmol) were dissolved in N,N-dimethylformamide (75 mL). N,N-Diisopropylethylamine (17.0 mL, 100
mmol) was added to the reaction mixture, which was stirred for 20
h at room temperature. The mixture was diluted with ethyl acetate
(500 mL) and washed with 10% aqueous solution of sodium sulfite (2
× 300 mL) and saturated aqueous solution of sodium chloride (1
× 100 mL). The organic layer was dried over anhydrous sodium
sulfate, filtered, and evaporated in vacuo. The residue was partially
purified by flash column chromatography (silica gel, 0.040–0.063
mm; eluent: cyclohexane/ethyl acetate 3:1), affording di-tert-butyl-3,3′-((anthracene-9,10-diylbis(methylene))bis-(azanediyl))dipropionate-methane 3 as an impure yellow solid. Compound 3 was further
purified by HPLC (Gemini C18 column, 5 μM, 250 mm × 50
mm, acetonitrile/water 5:95 during 20 min, 5:95 to 35:65 during 90
min, 35:65 to 55:45 during 60 min + 0.05% AcOH) to give acetate salt
as the pure product. To release the free amines, the material was
dissolved in dichloromethane (200 mL) and washed with 5% aqueous solution
of sodium carbonate (1 × 200 mL). The organic layer was dried
over anhydrous sodium sulfate, filtered, and evaporated in vacuo to
give di-tert-butyl-3,3′-((anthracene-9,10-diylbis(methylene))-bis(azanediyl))dipropionate-methane 3 as yellow crystals. Yield: 3.08 g (62%). 1H NMR
spectrum (300 MHz, CDCl3, δH): 8.40 (dd, J = 6.9 and 3.3 Hz, 4 H); 7.54 (dd, J =
6.9 and 3.2 Hz, 4 H); 4.73 (s, 4 H); 3.16 (t, J =
6.5 Hz, 4 H); 2.54 (t, J = 6.5 Hz, 4 H); 1.70 (s,
2 H); 1.42 (s, 18 H). LCMS m/z:
493.2 (M + H)+.
Synthesis of CF3 Toluene Pinacol
Boronate 5
(2-Methyl-5-(trifluoromethyl)phenyl)boronic
acid 4 (5.82 g, 28.5 mmol) and pinacol (3.37 g, 28.5
mmol) were
dissolved in ethyl acetate (60 mL). The reaction mixture was stirred
at room temperature for 1 h. The solvent was evaporated, and the residue
was co-evaporated with dichloromethane (3 × 100 mL). The residue
was crystallized from hot methanol (30 mL). The fine precipitate was
collected by filtration, washed with chilled (0 °C) methanol
(1 × 10 mL), and dried with suction in air and in vacuo to give
4,4,5,5-tetramethyl-2-(2-methyl-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane 5 as pale yellow crystals. Yield: 5.75 g (71%). 1H NMR spectrum (300 MHz, CDCl3, δH): 8.01 (s, 1
H); 7.65–7.45 (m, 1 H); 7.27 (d, 1 H); 2.59 (s, 3 H); 1.37
(s, 12 H).
Synthesis of Bromomethyl CF3 Phenyl
Pinacol Boronate 6
A mixture of 4,4,5,5-tetramethyl-2-(2-methyl-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane 5 4.86 g, 17.0 mmol), N-bromosuccinimide
(3.33 g, 18.7 mmol), and 2,2-azobis(2-methylbutyronitrile) (VAZOTM
67, 326 mg, 1.70 mmol) in acetonitrile (40 mL) was stirred at 80 °C
for 2 h, and then it was cooled to room temperature. The reaction
mixture was diluted with methyl tert-butyl ether (40 mL) and water
(40 mL). The organic layer was separated, washed with 10% aqueous
solution of sodium chloride (1 × 100 mL), dried over anhydrous
sodium sulfate, filtered, and evaporated in vacuo, affording a mixture
of product 6 and 2-(2-(dibromomethyl)-5-(trifluoromethyl)
phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane. The mixture (6.50
g, 17.8 mmol), diethyl phosphite (2.30 mL, 17.8 mmol), and N,N-diisopropylethylamine
(3.32 mL, 17.8 mmol) were dissolved in acetonitrile (30 mL) and stirred
at room temperature for 2 h. Afterward, the reaction mixture was diluted
with methyl tert-butyl ether (100 mL) and washed with 5% aqueous solution
of potassium bisulfate (2 × 100 mL) and saturated aqueous solution
of sodium chloride (1 × 100 mL). The organic layer was dried
over anhydrous sodium sulfate, filtered, and evaporated in vacuo.
The residue was crystallized from methanol/water mixture (7:3, 30
mL). When the crystallization was well advanced, the crystalline lumps
were pulverized with a spinning stir bar on ice-bath overnight. The
fine precipitate was collected by filtration, washed with chilled
(0 °C) methanol/water mixture (7:3, 1 × 50 mL), and dried
by suction in air and then in vacuo to give 2-(2-(bromomethyl)-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 6 as a white powder. Yield: 4.83 g (78%). 1H NMR
spectrum (300 MHz, CDCl3, δH): 8.08 (s, 1 H); 7.66
(dd, J = 8.0 and 1.5 Hz, 1 H); 7.51 (d, J = 8.1 Hz, 1 H); 4.92 (s, 2 H); 1.40 (s, 12 H).
Synthesis of
Pinacol Diboronate Anthracene 7
Di-tert-butyl-3,3′-((anthracene-9,10-diylbis(methylene))bis(azanediyl))-dipropionate-methane 3 (2.23 g, 4.52 mmol) and 2-(2-(bromomethyl)-5-(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 6 (3.62 g, 9.93 mmol) were dissolved in N,N-dimethylformamide (45 mL), and N,N-diisopropylethylamine (2.35 mL, 12.6 mmol) was
added. The reaction mixture was stirred at room temperature overnight.
The mixture was diluted with water (45 mL), and the precipitate was
collected by filtration, washed with water (2 × 20 mL), and air-dried
overnight to give slightly yellow crystals. The solid was triturated
with methanol (45 mL) and filtered, giving di-tert-butyl 3,3′-((anthracene-9,10-diylbis(methylene))
bis((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzyl)azanediyl))
dipropionate 7 as white crystals. Yield: 4.25 g (89%). 1H NMR spectrum (300 MHz, CDCl3, δH): 8.41
(dd, J = 6.8 and 3.2 Hz, 4 H); 7.92 (s, 2 H); 7.43
(dd, J = 16.4 and 7.6 Hz, 8 H); 4.54 (s, 4 H); 3.97
(s, 4 H); 2.93 (dd, J = 14.5 and 7.6 Hz, 4 H); 2.55
(t, J = 7.0 Hz, 4 H); 1.42–1.22 (m, 42 H).
LCMS m/z: 1061.8 (M + H)+.
Synthesis of Pinacol Diboronate Anthracene 8 (as
TFA Salt)
Di-tert-butyl 3,3′-((anthracene-9,10-diylbis(methylene))
bis((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzyl)azanediyl))
dipropionate (7, 1.50 g, 1.41 mmol) was dissolved in
trifluoroacetic acid (20 mL) and left to stand at room temperature
for 2 h. The mixture was evaporated in vacuo, dissolved in acetonitrile
(200 mL) and water (200 mL), and freeze-dried. The residue was purified
by HPLC (Gemini C18, 5 m, 250 mm × 50 mm, acetonitrile/water,
15:85 during 20 min, 15:85 to 45:55 during 90 min, 45:55 to 55:45
during 30 min + 0.05% AcOH) to give 3,3′-((anthracene-9,10-diylbis(methylene))bis((2-borono-4-(trifluoromethyl)benzyl)azanediyl))dipropionic
acid 8 as bis(trifluoroacetate) salt as a yellow powder.
Yield: 1.30 g (65%). 1H NMR spectrum (300 MHz, acetone-d6/D2O 10:1, δH): 8.34 (dd, J = 6.8 and 3.1 Hz, 4 H); 8.13 (s, 2 H), 7.88–7.46 (m, 8 H);
5.49 (s, 4 H); 4.82 (s, 4 H); 3.51 (t, J = 6.5 Hz,
4 H); 2.70 (t, J = 6.5 Hz, 4 H). 13C NMR
spectrum (75.6 MHz, acetone-d6/D2O 10:1, δC):
172.0 (COOH); 161.1 (q, J(C-F) = 35.0 Hz, COOH of TFA); 139.7 (Cq);
136.4 (diffuse, C-B); 135.5 (C-H); 132.5 (q, J(C-F) = 3.6 Hz, C-H);
131.1 (Cq anthr.); 130.1 (q, J(C-F) = 32 Hz), C-CF3); 127.7
(C-H anthr.); 127.1 (q, J(C-F) = 3.7 Hz, C-H); 125.1 (Cq anthr.);
124.3 (C-H anthr.); 124.1 (q, J(C-F) = 272 Hz), CF3 of
Ph); 116.6 (q, J(C-F) = 292 Hz), CF3 of TFA); 59.4 (CH2); 50.7 (CH2); 50.3 (CH2); 28.5 (CH2, partly overlapping with the acetone signal). 19F NMR
spectrum (282 MHz, acetone-d6/D2O 10:1, δF): −63.3
(s); −76.1 (s, TFA). LCMS m/z: 767.1 (M-H2O + H)+.
Stability of Diboronate
8 in Aqueous Solution at Neutral pH
Fluorophore 8 (25 μM) was dissolved in 0.1 M
phosphate buffer, pH 7.4, and left in an open vial versus shielded
vial (aluminum foil). Samples were analyzed daily by LCMS (column
1.7 μ C18 100 Å 2.1 × 50 mm, detector: PDA: 210–400
nm, scanning range: 100–1500). The chromatographic method used
a linear gradient of 10 to 90% B for a total runtime of 4 min, with
a flow rate of 0.3 mL/min and column temperature of 40 °C. Solvent
A, 0.1% TFA in water; solvent B, 0.1% TFA in CH3CN.
Fluorescence
Measurement of Dissociation Constant (Kd) of Fluorophore 8 toward Carbohydrates
and Other Relevant Compounds
A stock solution of fluorophore 8 (TFA salt, 1 mM) in 0.1 M phosphate buffer pH 7.4 was prepared.
The sugars were dissolved at the highest concentrations needed for
their individual titrations, in buffer containing 25 μM fluorophore,
and titrated in triplicate into 96-well black flat-bottom plates (Thermo-Fisher
Scientific). The fluorescence analysis was carried out at room temperature,
with the excitation wavelength at 360 ± 10 nm and emission scan
at 385–520 ± 10 nm. Data obtained for fluorescence intensity
were plotted versus sugar concentration (logarithmic scale) and fitted
(Prism 9.0.1, GraphPad) with the nonlinear regression function “log(agonist)
vs response-variable slope (four parameters)” to obtain the Kd value for the binding of diboronate 8 to each type of sugar.
Measurement of Limit of
Quantification for l-Glucose
The calibration curves
were handled by semilog plots, as generally
recommended for a nonlinear correlation between signal readout and
analyte concentration.[14,15] Lower and upper limits of quantification
(LLOQ and ULOQ, respectively) were determined by the two plateau regions
of the observed S-shaped curves and represent the assay range. Every
point of the calibration curve is measured in triplicate, and standard
deviations are represented by error bars. The analytical sensitivity
of the method is expressed by the LLOQ value according to FDA guidelines
for method validation. Linearity is evaluated by the R2 value of the linear regression.
Measurement of Relative
Fluorescence Quantum Yield for Diboronate 8
The quantum yield of fluorophore 8 (25 μM) in
0.1 M phosphate buffer pH 7.4 ± 0.5 mM nonglycated
albumin was determined by measuring the integrated emission area of
the fluorescence spectrum (λexc = 347 nm) and comparing
with the area measured for quinine sulfate (25 μM in HClO4 0.1 Μ, φ = 0.59, λexc = 347
nm). The equation used is the following:R stands for reference
and S for sample, φ
is the quantum yield, n is the refractive index of
the solvent, I is the fluorescence intensity, and A is the absorbance at the excitation wavelength (λex). Emission scan was performed at 385–700 nm.
Fluorescence
Polarization (Anisotropy) Experiment for the Measurement
of Dissociation Constant (Kd) of Albumin
Anisotropy (r) is defined as the ratio between
the difference of the fluorescence intensity emitted parallel and
perpendicular divided by the total intensity. First, a solution of
the highest albumin concentration and fluorophore 8 at
25 μM in 0.1 M phosphate buffer pH 7.4 was prepared and diluted
in 1:1 ratio with 25 μM of 8 into a 96-well black
flat-bottom plate at a final working volume of 150 μL. The fluorescence
measurements were carried out at room temperature using excitation
wavelength at 380 ± 10 nm and emission at 430 ± 15 nm, with
optimal gain and G-factor as calibrated from the reference and blank
well, 1.697. Polarization data were plotted versus the concentration
of HSA (logarithmic scale) and fitted (Prism 9.0.1, GraphPad) with
the previously described sigmoidal function to obtain the Kd value for the binding of the fluorophore 8 to HSA.
Results and Discussion
Carboxy anthracene
diboronate 8 was synthesized, as
outlined in Scheme . Compounds with free boronic acids tend to dehydrate to several
species during handling, which can complicate NMR analysis, and so
forth. For this reason, the boronates were protected as pinacols.
It is allegedly difficult to remove pinacol,[16,17] but we found that pinacol was easily removed during RP-HPLC under
aqueous acidic conditions, as employed for purification in the final
step, providing 8 as a free diboronic acid TFA salt.
Scheme 1
Synthesis of Fluorophore 8 as TFA Salt
Diboronates are fragile and can degrade during handling
and storage
of their aqueous solutions,[18] especially
when exposed to light. To investigate this point, aqueous solutions
of fluorophore 8 at neutral pH were stored in open vials,
compared to vials shielded from light using aluminum foil. By LCMS
analysis over 7 days, fluorophore 8 was found to be stable
when kept in the dark, whereas solutions of 8 exposed
to ambient light showed significant degradation over a few days (>30%).
During normal laboratory handling (preparation of titration series,
etc.), no shielding from light was found necessary.Fluorophore 8 can be excited at 380 nm, and its maximum
emission wavelength is 430 nm. However, in order to eliminate the
cross talk between excitation and emission, we recorded the fluorescent
readings with the excitation wavelength of 360 nm. When sugar is added
to 8, the emission spectra show two peaks with maximum
at 405 and 430 nm, respectively (Figure ).
Figure 1
Fluorescence emission of 8 when
titrated with l-glucose (λexc 360 nm) in
0.1 M phosphate
buffer pH 7.4 at room temperature.
Fluorescence emission of 8 when
titrated with l-glucose (λexc 360 nm) in
0.1 M phosphate
buffer pH 7.4 at room temperature.Dissociation constants (Kd) for 8 toward l-glucose and other substrates were measured
by plotting data from the titration series versus the employed sugar
concentrations and reading out Kd using
GraphPad Prism. Titration plots and curve fits can be seen in Figures and 2. Kd of 8 toward
both d- and l-glucose was found to be 0.44 mM, with
the minimum quantification limit for both enantiomers being 12 μM. l-glucose calibration curve is shown in Figure (semilog plot).[15] Measurements of d-glucose concentrations by using 8 were compared to values using a commercial glucometer (Abbott
FreeStyle Precision Neo). As mentioned, the glucometer could not measure l-glucose and gave an error message.
Figure 2
GraphPad plot of fluorescence
signal vs l-glucose logC (arbitrary units)
for the determination of Kd (λexc, 360 nm and λem, 430 nm) in 0.1 M phosphate
buffer pH 7.4 at room temperature. See
plots for other substrates in the Supporting Information. Inset: photograph of titration series taken under a UV lamp (285
nm).
Figure 3
Calibration curve for l-glucose (λexc, 360 nm and λem, 430 nm) in 0.1 M phosphate
buffer
pH 7.4 at room temperature.
GraphPad plot of fluorescence
signal vs l-glucose logC (arbitrary units)
for the determination of Kd (λexc, 360 nm and λem, 430 nm) in 0.1 M phosphate
buffer pH 7.4 at room temperature. See
plots for other substrates in the Supporting Information. Inset: photograph of titration series taken under a UV lamp (285
nm).Calibration curve for l-glucose (λexc, 360 nm and λem, 430 nm) in 0.1 M phosphate
buffer
pH 7.4 at room temperature.Dissociation constants of other investigated carbohydrates and
related compounds are listed in Table . Overall, the affinities follow rankings, as known
from other mono- and diboronates.[19]d-Fructose binds weaker than glucose to diboronate 8 (Kd, 2.5 mM and LOQ, 160 μM),
but it is noteworthy that fructose never reaches mM concentrations
in human circulation due to first-pass liver extraction.[20,21] Lactate, which can reach >10 mM values in human blood during
intense
exercise,[22] binds weakly to 8 with Kd of 22 mM. The strong binding
of 8 to catechol (Kd, 4 μM)
has precedence from other diborons, but catechol is not found in such
concentrations physiologically. Glucosides such as d-sucrose
and methyl mannopyranoside, as well as glucose-1-phosphate, bind very
weakly to 8 as the main binding motif of sugars, 1,2-cis-diol, is blocked in these substrates.
Table 1
Kd Values
of Fluorophore Diboronates 8 toward Sugars and Other
Substrates. See LLOD/ULOQ Values in Supporting Information
substrate
Kd (mM)
l-glucose
0.44
d-glucose
0.43
α-d-glucose
0.43
d-glucose with HSA 0.05 mM
3.5
d-glucose with HSA 0.5 mM
20
catechol
0.037
d-sorbose
0.27
d-tagatose
1.5
d-glucoronate sodium
1.6
d-sorbitol
2.3
d-fructose
2.5
d-galactose
7.2
d-ribose
8.2
d-mannose
14.4
sodium l-lactate
22.9
d-mannitol
64.0
α-d-lactose
68.0
2-deoxy-d-ribose
77.0
d-maltose
142
glycerol
158
methyl-α-d-mannopyranoside
160
erythritol
339
N-acetyl-d-glucosamine
575
d-sucrose
binding not saturated at 1
M
saccharin sodium
no binding
α-d-glucose-1-phosphate
no binding
sucralose
no binding
The mechanism of sugar
binding to boronates can involve mutarotation
of anomers toward the furanose form, as reported by Norrild et al.
using NMR experiments.[23] We observed that
pure alpha-d-glucose and common d-glucose, which
consist of a mixture of anomers with beta-d-pyranose as the
main component (67%), gave the same Kd value, indicating that glucose during contact with diboronate is
quickly pulled to a common anomer mixture, irrespective of the starting
configuration. The given readouts were recorded within minutes of
mixing, and we observed no change in readings over time, thus indicating
that the mutarotation of glucose in contact with diboronate 8 reaches completion within minutes, whereas the mutarotation
of neat glucose anomers takes approximately 30 min to reach equilibrium.[24]Notably, the sensitivity of fluorophore 8 to glucose
was found to decrease in solutions containing human serum albumin
(HSA, nonglycated). It has previously been described that nonfluorescent
diboronates can bind to albumin,[25,26] and this also
happens with fluorophore 8, whereby the fluorescence
signal is largely quenched. Human and animal blood as well as interstitial
liquid contains albumin in concentrations near 0.5 mM, and albumin
is known to bind many small molecules.[27,28] The exact
binding constants of albumin are generally difficult to determine
due to multiple binding pockets in the protein, meaning that titration
curves rarely give well-defined Kd values.
We tried to measure Kd of 8 of nonglycated albumin by simple titration with fluorescence readouts,
but the plot did not show a well-defined affinity value, probably
due to the binding of 8 to multiple albumin-binding pockets
with overlapping Kd values. Fluorescence
polarization (anisotropy) was shown to be a better approach, and by
titration of albumin against a fixed concentration of fluorophore 8 (5 μM), we saw a sigmoidal curve, with Kd reading out as 2 μM (Figure ). By the Job plot analysis (see Supporting Information),[29] the binding stoichiometry was found to be 4:1, which makes sense
considering the multiple binding pockets in albumin. The displacement
of fluorophore 8 from albumin by warfarin (Sudlow site
1) and ibuprofen (site 2) was also studied by anisotropic fluorescence.
Quantitative data could not be collected, likely due to the mixed
binding of 8 to several HSA-binding pockets, but qualitatively, 8 appears to bind at least to site 1 and site 2 (see Supporting Information).
Figure 4
Anisotropy titration
of albumin vs 8 for the determination
of Kd = 2 μM (λexc, 380 nm and λem, 430 nm) in 0.1 M phosphate buffer
pH 7.4 at room temperature.
Anisotropy titration
of albumin vs 8 for the determination
of Kd = 2 μM (λexc, 380 nm and λem, 430 nm) in 0.1 M phosphate buffer
pH 7.4 at room temperature.Finally, we measured the relative fluorescence quantum yields (φ)
of 8 in phosphate buffer pH 7.4 compared to the solution
with 0.5 mM nonglycated albumin, using quinine sulfate in 0.1 M HClO4 as reference (φ = 0.59).[30,31] Albumin quenched
fluorescence of 8 with an eightfold decrease in quantum
yield, from 0.16 in simple buffer to 0.02 in albumin-containing solution.
Accordingly, more work would be required in order to use 8 for measuring carbohydrates in blood samples, with albumin present.
The reason Eversense probe can work in vivo despite the presence of
albumin is probably the use of a membrane that hinders contact between
diboronate and albumin. Unfortunately, Eversense probe is not suited
for laboratory use, as discussed above.
Conclusions
In
conclusion, the water-soluble diboronate fluorophore 8 was synthesized by a facile five-step route, and 8 was
found to be stable to long-term storage in aqueous solutions when
shielded from ambient light. The fluorophore could be used to measure l-glucose, showing Kd of 0.44 mM
and LOQ of 12 μM. The physiological concentration of albumin
(0.5 mM) largely quenched the fluorescence signal of 8; hence, using 8 for measurements of l-glucose
in blood samples would require more work. It seems likely that other
fluorescent diboronates from the literature can have similar interactions
with albumin, and this should be considered for future design and
evaluation of diboronates for sugar detection.